News Daily News Long-term MI Risk Among Stable CAD Patients: Some Clues From CORONOR Shelley Wood April 24, 2017
News Daily News ACC/AHA ‘Very High Risk’ Criteria Only Modestly Predict Recurrent Events Michael O'Riordan April 04, 2017
News Conference News ACC 2017 High-Dose Atorvastatin Does Not Impact Cognition, but Small Changes Observed on Brain MRI Michael O'Riordan March 21, 2017
News Conference News ACC 2017 FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo Michael O'Riordan March 17, 2017
News Daily News Updated AUC for Stable Ischemic Heart Disease Seek to Match ‘Appropriateness’ to Current Practice Caitlin E. Cox March 10, 2017
News Daily News Meta-analysis Calls Into Question Strength of Guidance for RAS Blockade in Patients With Stable CAD Todd Neale January 19, 2017
News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Features Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más Shelley Wood December 30, 2016
News Daily News High-Sensitivity Troponin Assays May Help With Response to Statins and Other Meds Todd Neale December 19, 2016
News Daily News Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies Michael O'Riordan September 27, 2016
News Daily News Many Guidelines, Mixed Consensus: Different CVD Risk Guidelines Cause Confusion in Practice Michael O'Riordan September 16, 2016
News Daily News Demasiados Elementos en Juego: La Existencia de Diferentes y Discordantes Directrices Hace que la Valoración del Riesgo de ECV sea Confusa Michael O'Riordan September 16, 2016
News Daily News Nearly 40% of Diabetic Patients Not Treated With Statins: PINNACLE Registry Michael O'Riordan September 13, 2016
News Daily News Review Touts Benefits of Statins, Seeks to Dispel Safety Concerns Todd Neale September 12, 2016
News Daily News Short-term DAPT Not Necessarily the Best Option for All, Especially After Complex PCI Yael L. Maxwell September 02, 2016
News Daily News El Tratamianto Antiplaquetario Doble a Corto Plazo No es la Mejor Opción para Todos, Especialmente Tras una PCI Compleja Yael L. Maxwell September 02, 2016
News Conference News ESC 2016 Ezetimibe Plus Pitavastatin Fails to Lower Risk of CVD Events in ACS Patients: HIJ-PROPER Michael O'Riordan August 30, 2016
News Conference News ESC 2016 Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say Michael O'Riordan August 27, 2016